ENTITY
JD Health International

JD Health International (6618 HK)

433
Analysis
Consumer Staples • China
JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.
more
bullish•Pop Mart
•10 Dec 2020 09:28

Pop Mart IPO Trading - Set for a Pop but We Won't Be Chasing

POP MART raised around US$775m in its Hong Kong IPO. Pop Mart is the largest and fastest growing pop toy company in China, in terms of 2019 revenue...

Logo
519 Views
Share
•09 Dec 2020 08:48

JD Health (京东偄康) Quick Note - Index Inclusions, Weights, and Valuation Update

JD Health (6618 HK) closed +56% higher on its trading debut. Post market close, MSCI and FTSE announced JDH's early inclusion and fast entry,...

Share
•07 Dec 2020 17:04

JD Health IPO: Trading Debut

JD Health priced its IPO at HK$70.58 and opened 19% higher at HK$84.00 in the grey market. Our DCF sensitivity analysis shows that the IPO price...

Logo
668 Views
Share
•07 Dec 2020 16:41

JD Health (京东偄康) IPO Trading - Looking to Be a Solid Debut

JD Health (6618 HK) raised US$3.5bn in its Hong Kong IPO, priced at HK$70.58 per share, at the top-end of its price range.

Share
•06 Dec 2020 11:36

ECM Weekly (6 December 2020) - Blue Moon Group, Pop Mart, HBM, Burger King India, and More

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Share
x